Cite
Co-Delivery of Repurposing Itraconazole and VEGF siRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer.
MLA
Jin, Mingji, et al. “Co-Delivery of Repurposing Itraconazole and VEGF SiRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer.” Pharmaceutics, vol. 14, no. 7, July 2022, p. N.PAG. EBSCOhost, https://doi.org/10.3390/pharmaceutics14071369.
APA
Jin, M., Zeng, B., Liu, Y., Jin, L., Hou, Y., Liu, C., Liu, W., Wu, H., Chen, L., Gao, Z., & Huang, W. (2022). Co-Delivery of Repurposing Itraconazole and VEGF siRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer. Pharmaceutics, 14(7), N.PAG. https://doi.org/10.3390/pharmaceutics14071369
Chicago
Jin, Mingji, Bowen Zeng, Yanhong Liu, Lili Jin, Yan Hou, Chao Liu, Wei Liu, et al. 2022. “Co-Delivery of Repurposing Itraconazole and VEGF SiRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer.” Pharmaceutics 14 (7): N.PAG. doi:10.3390/pharmaceutics14071369.